Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Effects of a Recreational Team Handball-based Programme on Health and Physical Fitness of Postmenopausal Women (H4HW)

maanantai 28. maaliskuuta 2022 päivittänyt: Susana Cristina Araújo Póvoas, University Institute of Maia

Effects of a Short- and Long-term Team Handball-based Exercise Programme on Physical Fitness and Health Status of Inactive Postmenopausal Women

This study aimed at determining the short- (16 weeks) and long-term (36 weeks) health and physical fitness effects and adherence of recreational team handball training for postmenopausal women without previous experience with the sport.

The investigators hypothesized that short-term recreational team handball training would result in positive health and physical fitness adaptations and that the health and physical fitness improvements achieved after the first 16 weeks would be maintained or further improved at the long-term. Moreover, the investigators also hypothesized that the adherence to this exercise mode would be maintained throughout the 36 weeks (long-term) compared to the first 16 weeks (short-term).

Tutkimuksen yleiskatsaus

Tila

Valmis

Ehdot

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

80

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Porto
      • Maia, Porto, Portugali, 4476-690
        • University of Maia

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Lapsi
  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Nainen

Kuvaus

Inclusion Criteria:

  • Inactive postmenopausal women aged +55 years or younger if with menopause for at least 3 years

Exclusion Criteria:

  • Any medical contraindications to perform moderate-to-vigorous physical activity

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Ennaltaehkäisy
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Team handball group
The team handball group participants were encouraged to performed at least two out of three weekly supervised team handball training sessions of 60 min each, for 36 weeks.
Two to three weekly sessions of recreational team handball training for 36 weeks. Each 60-min session started with a standardised warm-up (including running, coordination, strength, flexibility, and balance exercises) followed by three 15-min periods of recreational team handball matches, interspersed by 2-min breaks, played as small-sided games (4v4, 5v5 or 6v6). The training sessions were performed on an indoor team handball court (40x20 m) adjusted to result in 34-36 m2 per player. During the matches, the participants rotated positions every 3 min in a random order, including the goalkeeper and no exclusions or substitutions were applied.
Ei väliintuloa: Control group
The control group participants were instructed to keep their regular daily physical activity for 36 weeks.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Between group differences in peak oxygen uptake at week 16
Aikaikkuna: Week 16
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 16
Between group differences in peak oxygen uptake at week 36
Aikaikkuna: Week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 36
Changes from baseline in peak oxygen uptake at week 16
Aikaikkuna: Baseline and week 16
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Baseline and week 16
Changes from baseline in peak oxygen uptake at week 36
Aikaikkuna: Baseline and week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Baseline and week 36
Changes from week 16 in peak oxygen uptake at week 36
Aikaikkuna: Week 16 and week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 16 and week 36

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Between group differences in resting heart rate at week 16
Aikaikkuna: Week 16
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 16
Between group differences in resting heart rate at week 36
Aikaikkuna: Week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 36
Changes from baseline in resting heart rate at week 16
Aikaikkuna: Baseline and week 16
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Baseline and week 16
Changes from baseline in resting heart rate at week 36
Aikaikkuna: Baseline and week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Baseline and week 36
Changes from week 16 in resting heart rate at week 36
Aikaikkuna: Week 16 and week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 16 and week 36
Between group differences in body mass at week 16
Aikaikkuna: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in body mass at week 36
Aikaikkuna: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in body mass at week 16
Aikaikkuna: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in body mass at week 36
Aikaikkuna: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in body mass at week 36
Aikaikkuna: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in fat mass at week 16
Aikaikkuna: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in fat mass at week 36
Aikaikkuna: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in fat mass at week 16
Aikaikkuna: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in fat mass at week 36
Aikaikkuna: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in fat mass at week 36
Aikaikkuna: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in lean mass at week 16
Aikaikkuna: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in lean mass at week 36
Aikaikkuna: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in lean mass at week 16
Aikaikkuna: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in lean mass at week 36
Aikaikkuna: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in lean mass at week 36
Aikaikkuna: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in lumbar spine bone mineral density at week 16
Aikaikkuna: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in lumbar spine bone mineral density at week 36
Aikaikkuna: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in lumbar spine bone mineral density at week 16
Aikaikkuna: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in lumbar spine bone mineral density at week 36
Aikaikkuna: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in lumbar spine bone mineral density at week 36
Aikaikkuna: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femur bone mineral density at week 16
Aikaikkuna: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femur bone mineral density at week 36
Aikaikkuna: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femur bone mineral density at week 16
Aikaikkuna: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femur bone mineral density at week 36
Aikaikkuna: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femur bone mineral density at week 36
Aikaikkuna: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femoral neck bone mineral density at week 16
Aikaikkuna: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femoral neck bone mineral density at week 36
Aikaikkuna: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femoral neck bone mineral density at week 16
Aikaikkuna: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femoral neck bone mineral density at week 36
Aikaikkuna: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femoral neck bone mineral density at week 36
Aikaikkuna: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in lumbar spine bone mineral content at week 16
Aikaikkuna: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in lumbar spine bone mineral content at week 36
Aikaikkuna: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in lumbar spine bone mineral content at week 16
Aikaikkuna: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in lumbar spine bone mineral content at week 36
Aikaikkuna: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in lumbar spine bone mineral content at week 36
Aikaikkuna: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femur bone mineral content at week 16
Aikaikkuna: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femur bone mineral content at week 36
Aikaikkuna: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femur bone mineral content at week 16
Aikaikkuna: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femur bone mineral content at week 36
Aikaikkuna: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femur bone mineral content at week 36
Aikaikkuna: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femoral neck bone mineral content at week 16
Aikaikkuna: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femoral neck bone mineral content at week 36
Aikaikkuna: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femoral neck bone mineral content at week 16
Aikaikkuna: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femoral neck bone mineral content at week 36
Aikaikkuna: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femoral neck bone mineral content at week 36
Aikaikkuna: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in osteocalcin at week 16
Aikaikkuna: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in osteocalcin at week 36
Aikaikkuna: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in osteocalcin at week 16
Aikaikkuna: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in osteocalcin at week 36
Aikaikkuna: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in osteocalcin at week 36
Aikaikkuna: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in procollagen type-1 amino-terminal propeptide at week 16
Aikaikkuna: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in procollagen type-1 amino-terminal propeptide at week 36
Aikaikkuna: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in procollagen type-1 amino-terminal propeptide at week 16
Aikaikkuna: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in procollagen type-1 amino-terminal propeptide at week 36
Aikaikkuna: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in procollagen type-1 amino-terminal propeptide at week 36
Aikaikkuna: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in carboxy-terminal type-1 collagen crosslinks at week 16
Aikaikkuna: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in carboxy-terminal type-1 collagen crosslinks at week 36
Aikaikkuna: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in carboxy-terminal type-1 collagen crosslinks at week 16
Aikaikkuna: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in carboxy-terminal type-1 collagen crosslinks at week 36
Aikaikkuna: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in carboxy-terminal type-1 collagen crosslinks at week 36
Aikaikkuna: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in sclerostin at week 16
Aikaikkuna: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in sclerostin at week 36
Aikaikkuna: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in sclerostin at week 16
Aikaikkuna: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in sclerostin at week 36
Aikaikkuna: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in sclerostin at week 36
Aikaikkuna: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in isometric knee extension peak torque at week 16
Aikaikkuna: Week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16
Between group differences in isometric knee extension peak torque at week 36
Aikaikkuna: Week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 36
Changes from baseline in isometric knee extension peak torque at week 16
Aikaikkuna: Baseline and week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 16
Changes from baseline in isometric knee extension peak torque at week 36
Aikaikkuna: Baseline and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 36
Changes from week 16 in isometric knee extension peak torque at week 36
Aikaikkuna: Week 16 and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16 and week 36
Between group differences in isometric knee extension rate of force development at week 16
Aikaikkuna: Week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16
Between group differences in isometric knee extension rate of force development at week 36
Aikaikkuna: Week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 36
Changes from baseline in isometric knee extension rate of force development at week 16
Aikaikkuna: Baseline and week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 16
Changes from baseline in isometric knee extension rate of force development at week 36
Aikaikkuna: Baseline and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 36
Changes from week 16 in isometric knee extension rate of force development at week 36
Aikaikkuna: Week 16 and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16 and week 36
Between group differences in upper body strength at week 16
Aikaikkuna: Week 16
Determined by a handgrip dynamometer.
Week 16
Between group differences in upper body strength at week 36
Aikaikkuna: Week 36
Determined by a handgrip dynamometer.
Week 36
Changes from baseline in upper body strength at week 16
Aikaikkuna: Baseline and week 16
Determined by a handgrip dynamometer.
Baseline and week 16
Changes from baseline in upper body strength at week 36
Aikaikkuna: Baseline and week 36
Determined by a handgrip dynamometer.
Baseline and week 36
Changes from week 16 in upper body strength at week 36
Aikaikkuna: Week 16 and week 36
Determined by a handgrip dynamometer.
Week 16 and week 36
Between group differences in postural balance at week 16
Aikaikkuna: Week 16
Determined by the number of falls in a single-legged flamingo balance test.
Week 16
Between group differences in postural balance at week 36
Aikaikkuna: Week 36
Determined by the number of falls in a single-legged flamingo balance test.
Week 36
Changes from baseline in postural balance at week 16
Aikaikkuna: Baseline and week 16
Determined by the number of falls in a single-legged flamingo balance test.
Baseline and week 16
Changes from baseline in postural balance at week 36
Aikaikkuna: Baseline and week 36
Determined by the number of falls in a single-legged flamingo balance test.
Baseline and week 36
Changes from week 16 in postural balance at week 36
Aikaikkuna: Week 16 and week 36
Determined by the number of falls in a single-legged flamingo balance test.
Week 16 and week 36
Between group differences in aerobic performance at week 16
Aikaikkuna: Week 16
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 16
Between group differences in aerobic performance at week 36
Aikaikkuna: Week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 36
Changes from baseline in aerobic performance at week 16
Aikaikkuna: Baseline and week 16
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Baseline and week 16
Changes from baseline in aerobic performance at week 36
Aikaikkuna: Baseline and week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Baseline and week 36
Changes from week 16 in aerobic performance at week 36
Aikaikkuna: Week 16 and week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 16 and week 36
Between group differences in total cholesterol at week 16
Aikaikkuna: Week 16
Determined by an automated analyser.
Week 16
Between group differences in total cholesterol at week 36
Aikaikkuna: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in total cholesterol at week 16
Aikaikkuna: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in total cholesterol at week 36
Aikaikkuna: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in total cholesterol at week 36
Aikaikkuna: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in high-density lipoprotein cholesterol at week 16
Aikaikkuna: Week 16
Determined by an automated analyser.
Week 16
Between group differences in high-density lipoprotein cholesterol at week 36
Aikaikkuna: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in high-density lipoprotein cholesterol at week 16
Aikaikkuna: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in high-density lipoprotein cholesterol at week 36
Aikaikkuna: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in high-density lipoprotein cholesterol at week 36
Aikaikkuna: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in low-density lipoprotein cholesterol at week 16
Aikaikkuna: Week 16
Determined by an automated analyser.
Week 16
Between group differences in low-density lipoprotein cholesterol at week 36
Aikaikkuna: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in low-density lipoprotein cholesterol at week 16
Aikaikkuna: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in low-density lipoprotein cholesterol at week 36
Aikaikkuna: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in low-density lipoprotein cholesterol at week 36
Aikaikkuna: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in triglycerides at week 16
Aikaikkuna: Week 16
Determined by an automated analyser.
Week 16
Between group differences in triglycerides at week 36
Aikaikkuna: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in triglycerides at week 16
Aikaikkuna: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in triglycerides at week 36
Aikaikkuna: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in triglycerides at week 36
Aikaikkuna: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in fasting glucose at week 16
Aikaikkuna: Week 16
Determined by an automated analyser.
Week 16
Between group differences in fasting glucose at week 36
Aikaikkuna: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in fasting glucose at week 16
Aikaikkuna: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in fasting glucose at week 36
Aikaikkuna: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in fasting glucose at week 36
Aikaikkuna: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in fasting insulin at week 16
Aikaikkuna: Week 16
Determined by an automated analyser.
Week 16
Between group differences in fasting insulin at week 36
Aikaikkuna: Week 36
Determined by an automated analyser.
Week 36
Change from baseline in fasting insulin at week 16
Aikaikkuna: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Change from baseline in fasting insulin at week 36
Aikaikkuna: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Change from week 16 in fasting insulin at week 36
Aikaikkuna: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in glucose tolerance at week 16
Aikaikkuna: Week 16
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 16
Between group differences in glucose tolerance at week 36
Aikaikkuna: Week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 36
Changes from baseline in glucose tolerance at week 16
Aikaikkuna: Baseline and week 16
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Baseline and week 16
Changes from baseline in glucose tolerance at week 36
Aikaikkuna: Baseline and week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Baseline and week 36
Changes from week 16 in glucose tolerance at week 36
Aikaikkuna: Week 16 and week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 16 and week 36

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Lauantai 2. tammikuuta 2016

Ensisijainen valmistuminen (Todellinen)

Torstai 1. maaliskuuta 2018

Opintojen valmistuminen (Todellinen)

Torstai 1. maaliskuuta 2018

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Maanantai 14. maaliskuuta 2022

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Maanantai 14. maaliskuuta 2022

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 23. maaliskuuta 2022

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Keskiviikko 6. huhtikuuta 2022

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Maanantai 28. maaliskuuta 2022

Viimeksi vahvistettu

Tiistai 1. maaliskuuta 2022

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • CEFADE202019

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa